Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Search Results for: COVID-19

Lab Directors Develop Plans for Return of Routine Hospital Care

CLINICAL LABORATORY DIRECTORS IN MICHIGAN are developing plans to test patients who will return when hospitals reopen for routine care. Included in those plans are strategies to do testing for the novel coronavirus on patients who will return for everyday care and elective procedures, said Barton P. Buxton, EdD, President and CEO of McLaren Health Management Group. MHMG provides laboratory and other services in …

Lab Directors Develop Plans for Return of Routine Hospital Care Read More »

To access this post, you must purchase The Dark Report.

June 1, 2020 Intelligence: Late-Breaking Lab News

Daily, national news headlines call attention to the lack of adequate testing for COVID-19. News reporters question why clinical labs are unable to meet the demand for SARS-CoV-2 tests. One major reason is the lack of adequate supplies labs need to collect specimens, transport them, and perform COVID-19 tests in large numbers. This is one finding of a study conducted by the Association for Molecular Pathology (AMP). In a press release …

June 1, 2020 Intelligence: Late-Breaking Lab News Read More »

To access this post, you must purchase The Dark Report.

Volume XXVII No. 7 – May 11, 2020

LABS CAN REST EASIER knowing that the initial flood of unvalidated faulty or fraudulent serological COVID-19 tests is being halted now that the FDA has done an about-face on its policies. And THE DARK REPORT offers behind-the-scenes insights into the COVID-19 Testing Project which used a multidisciplinary effort to analyze and compare the performance of 12 of these tests. In other good news, THE DARK REPORT reports on a potential new revenue source for cash-strapped labs.

California Research Team Analyzes Performance of 12 Serological Tests

This is an excerpt of a 2.241-word article in the May 11, 2020 issue of THE DARK REPORT (TDR). The full article is available to members of The Dark Intelligence Group. CEO SUMMARY: Researchers with the COVID-19 Testing Project used a multidisciplinary effort to analyze and compare the performance of 12 serological tests, and shared their results with …

California Research Team Analyzes Performance of 12 Serological Tests Read More »

To access this post, you must purchase The Dark Report.

Expert Offers Comments on FDA and Revised Serology Test Rules

CLINICAL LABORATORY DIRECTORS are asking what caused the federal Food and Drug Administration (FDA) to issue a highly questionable policy in March to allow serological tests for SARS-CoV-2 and then change that policy seven weeks later. Under a policy the agency issued March 16, the FDA granted what it called “regulatory flexibility for developers offering such tests without FDA review and without an emergency use …

Expert Offers Comments on FDA and Revised Serology Test Rules Read More »

To access this post, you must purchase The Dark Report.

California Research Team Analyzes Performance of 12 Serology Tests

CEO SUMMARY: Researchers with the COVID-19 Testing Project used a multidisciplinary effort to analyze and compare the performance of 12 serological tests. One finding is that, 16 to 20 days or more after a confirmed infection with a molecular test, many of the 12 serological tests analyzed were 80% positive. Using donated blood samples, the researchers assessed the volume and …

California Research Team Analyzes Performance of 12 Serology Tests Read More »

To access this post, you must purchase The Dark Report.

To Stay Afloat, Dallas AP Group Cut Staff, Payroll

CEO SUMMARY: As early cases of COVID-19 spread in some states, pathologists at the 50-member ProPath group in Dallas prepared for a widespread outbreak by preserving cash and working with bankers and other advisors to apply for federal stimulus funding. Executives also furloughed pathologists and other staff temporarily before using federal funds to bring them back. Despite a 65% drop in …

To Stay Afloat, Dallas AP Group Cut Staff, Payroll Read More »

To access this post, you must purchase The Dark Report.

MAY 11, 2020 Intelligence: Late-Breaking Lab News

Clinical laboratories in other countries have similar challenges in responding to the COVID-19 pandemic. In the United Kingdom, the Independent reported last week that “Widespread testing for coronavirus has been suspended among staff and patients at hospitals and GP practices serving 3.5 million people because of a shortage of vital chemicals.” According to Independent reporter Shaun Lintern, medical laboratories serving South London are unable to access adequate supplies of reagents and other …

MAY 11, 2020 Intelligence: Late-Breaking Lab News Read More »

To access this post, you must purchase The Dark Report.

  Add Dark Daily news RSS to your website or RSS reader with this URL https://www.darkdaily.com/feed/Free ebrief membership at DarkDaily.com   •  Read all Dark Daily coverage about COVID-19 •  Read all Dark Report articles about COVID-19  JOIN Dark Daily today and get free laboratory news ebriefs in your inbox.    

Volume XXVII No. 6 – April 20, 2020

COVID-19 NEWS IS HITTING the laboratory industry hard. With specimens — and therefore revenues — in a deep dive, lab finances are crashing, and COVID-19 testing isn’t entirely making up for the losses. But THE DARK REPORT shows labs how and where to apply for financial aid under federal relief packages. Meanwhile, a pre-eminent pathologist takes readers deep inside the Italian pandemic in an exclusive interview.

;